A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Xu, Xindong ^a   Zhang, Dongmei ^b   Sun, Wei ^a   Zhang, Qingfeng ^a   Zhang, Jingjing ^a   Xue, Xiangyang ^a   Shen, Luhui ^b   Pan, Weiqing ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; CHIMERIC SCHISTOSOMA JAPONICUM GLITATHIONE S TRANSFERASE; CHIMERIC SCHISTOSOMA JAPONICUM GLUTATHIONE PROTEIN 1; CHIMERIC SCHISTOSOMA JAPONICUM GLUTATHIONE PROTEIN 2; CHIMERIC SCHISTOSOMA JAPONICUM GLUTATHIONE PROTEIN 3; CHIMERIC SCHISTOSOMA JAPONICUM GLUTATHIONE PROTEIN 4; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; MONTANIDE IMS 1312; MONTANIDE ISA 206; MONTANIDE ISA 70M; PARAMYOSIN; UNCLASSIFIED DRUG; HELMINTH ANTIBODY; HELMINTH PROTEIN; HYBRID PROTEIN; PARASITE ANTIGEN; SUBUNIT VACCINE; TROPOMYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SCREENING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SCHISTOSOMIASIS; TH1 CELL; TH2 CELL; THERAPY EFFECT; ANIMAL; BAGG ALBINO MOUSE; BLOOD; ESCHERICHIA COLI; FEMALE; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PICHIA; RABBIT; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SNAIL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ESCHERICHIA COLI; FEMALE; HELMINTH PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-4; LIVER; MICE; MICE, INBRED BALB C; PICHIA; RABBITS; RECOMBINANT FUSION PROTEINS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SNAILS; TH1 CELLS; TROPOMYOSIN; VACCINES, SUBUNIT;

EID: 66149095461     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-54     Document Type: Article

References (47)

1. World Health Organization The prevention and control of schistosemiasis and soil-transmitted helminthiasis Report of the Joint WHO Expert Committees WHO Technical Report Series 4:2002
2. Utzinger J Zhou XN Chen MG Bergquist R Conquering schistosomiasis in China: The long march Acta Trop 2005, 96:69-96 16312039
3. McManus DP Bartley PB A vaccine against Asian schistosomiasis Parasitol Int 2004, 53:163-173 15081948
4. Pearce EJ Progress towards a vaccine for schistosomiasis Acta Trop 2003, 86:309-313 12745147
5. Bergquist R Al-Sherbiny M Barakat R Olds R Blueprint for schistosomiasis vaccine development Acta Trop 2002, 82:183-192 12020891
6. Gobert GN Immunolocalization of schistosome proteins Microsc Res Tech 1998, 429:176-185
7. Gobert GN Stenzel DJ McManus DP Immunolocalisation of the glutathione S-transferases, GST-26 and GST-28, within adult Schistosoma japonicum Int J Parasitol 1998, 28:1437-1443 9770630
8. Mitchell GF Glutathione S-transferases - potential components of anti-schistosome vaccines? Parasitol Today 1989, 5:34-37 15463173
9. Liu S Song G Xu Y Yang W McManus DP Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum Vaccine 1995, 13:603-607 7483782
10. McManus DP Wong JY Zhou J Cai C Zeng Q Smyth D Li Y Kalinna BH Duke MJ Yi X Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes Vaccine 2001, 20:870-878 11738752
11. McManus DP Liu S Song G Xu Y Wong JM The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum Int J Parasitol 1998, 28:1739-1742 9846611
12. Zhang DM Pan WQ Qian L Duke M Shen LH McManus DP Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice Parasite Immunol 2006, 28:77-84 16441505
13. Hu J Chen Z Gu J Wan M Shen Q Kieny MP He J Li Z Zhang Q Reed ZH Zhu Y Li W Cao Y Qu L Cao Z Wang Q Liu H Pan X Huang X Zhang D Xue X Pan W Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults PLoS ONE 2008:3
14. Pan W Huang D Zhang Q Qu L Zhang D Zhang X Xue X Qian F Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro J Immunol 2004, 172:6167-6174 15128804
15. Zhang Q Xue X Qu L Pan W Construction and evaluation of a multistage combination vaccine against malaria Vaccine 2007, 25:2112-2119 17241708
16. Wynn TA Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology Microbes Infect 1999, 1:525-534 10603569
17. Golding B Scott DE Vaccine strategies: Targeting helper T cell responses Ann N Y Acad Sci 1995, 754:126-137 7625646
18. Rosane HCC Padraic GF Michael JD Sm480: A high molecule weight Schistosoma mansoni antigen associated with protective immunity Parasite Immunol 1996, 18:149-157 9223169
19. Sharp PM Cowe E Higgins DG Shields DC Wolfe KH Wright F Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens; a review of the considerable within-species diversity Nucleic Acids Res 1988, 16:8207-8211 338553 3138659
20. Pan W Ravot E Tolle R Frank R Mosbach R Turbachova I Bujard H Vaccine candidate MSP-1 from Plasmodium falciparum: A redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells Nucleic Acids Res 1999, 27:1094-1103 148291 9927744
21. Stoscheck CM Quantitation of protein Methods Enzymol 1990, 182:50-68 2314256
22. Daynes RA Dowell T Araneo BA Platelet-derived growth factor is a potent biologic response modifier of T cells J Exp Med 1991, 174:1323-1333 2119044 1660523
23. Schumacher JH O'Garra A Shrader B van Kimmenade A Bond MW Mosmann TR Coffman RL The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent J Immunol 1988, 141:1576-1581 2970507
24. Wilson RA Coulson PS Why don't we have a schistosomiasis vaccine? Parasitol Today 1998, 14:97-99 17040714
25. World Health Organization Tropical diseases research no 50 World Health Organization, Geneva, Switzerland 1996
26. James SL Natovitz PC Farrar WL Leonard EJ Macrophages as effector cells of protective immunity in murine schistosomiasis: Macrophage activation in mice vaccinated with radiation-attenuated cercariae Infect Immun 1984, 44:569-575 263629 6609885
27. Kariuki TM Van Dam GJ Deelder AM Farah IO Yole DS Wilson RA Coulson PS Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine Infect Immun 2006, 74:3979-3986 1489735 16790771
28. Capron M Capron A Immunoglobulin E and effector cells in schistosomiasis Science 1994, 264:1876-1877 8009216
29. Couissinier-Paris P Dessein AJ Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2 Eur J Immunol 1995, 25:2295-2302 7545117
30. Hagan P Blumenthal UJ Dunn D Simpson AJ Wilkins HA Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium Nature 1991, 349:243-245 1898985
31. Woolhouse ME Taylor P Matanhire D Chandiwana SK Acquired immunity and epidemiology of Schistosoma haematobium Nature 1991, 351:757-759 1905786
32. Pearce EJ MacDonald AS The immunobiology of schistosomiasis Nat Rev Immunol 2002, 2:499-511 12094224
33. Cheever AW Williams ME Wynn TA Finkelman FD Seder RA Cox TM Hieny S Caspar P Sher A Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis J Immunol 1994, 153:753-759 8021510
34. Czaja MJ Weiner FR Takahashi S Giambrone MA Meide van der PH Schellekens H Biempica L Zern MA Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis Hepatology 1989, 10:795-800 2509321
35. Wynn TA Cheever AW Jankovic D Poindexter RW Caspar P Lewis FA Sher A An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection Nature 1995, 376:594-596 7637808
36. Boros DL Whitfield JR Enhanced Th1 and dampened Th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine schistosomiasis mansoni Infect Immun 1999, 67:1187-1193 96445 10024559
37. Jankovic D Kullberg MC Noben-Trauth N Caspar P Ward JM Cheever AW Paul WE Sher A Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile J Immunol 1999, 163:337-342 10384133
38. Kaplan MH Whitfield JR Boros DL Grusby MJ Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response J Immunol 1998, 160:1850-1856 9469446
39. James SL Glaven J Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates J Immunol 1989, 143:4208-4212 2592772
40. Kelly EA Colley DG In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni Reduction of irradiated cercariae-induced resistance J Immunol 1988, 140:2737-2745 3128606
41. Chen Y Boros DL Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas Infect Immun 1999, 67:4570-4577 96780 10456902
42. Zhang R Yoshida A Kumagai T Kawaguchi H Maruyama H Suzuki T Itoh M El-Malky M Ohta N Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum Infect Immun 2001, 69:386-391 97894 11119528
43. Guo J Li Y Gray D Ning A Hu G Chen H Davis GM Sleigh AC Feng Z McManus DP Williams GM A drug-based intervention study on the importance of buffaloes for human Schistosoma japonicum infection around Poyang Lake, People's Republic of China Am J Trop Med Hyg 2006, 74:335-341 16474093
44. Williams GM Sleigh AC Li Y Feng Z Davis GM Chen H Ross AG Bergquist R McManus DP Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China Acta Trop 2002, 82:253-262 12020899
45. Deville S Pooter A Aucouturier J Laine-Prade V Cote M Boireau P Vallee I Influence of adjuvant formulation on the induced protection of mice immunized with total soluble antigen of Trichinella spiralis Vet Parasitol 2005, 132:75-80 15990233
46. Dupuis L Ascarateil S Aucouturier J Ganne V SEPPIC vaccine adjuvants for poultry Ann N Y Acad Sci 2006, 1081:202-205 17135512
47. Lightowlers MW Lawrence SB Gauci CG Young J Ralston MJ Maas D Health DD Vaccination against hydatidosis using a defined recombinant antigen Parasite Immunol 1996, 18:457-462 9226681